vs

Side-by-side financial comparison of FIDELITY D & D BANCORP INC (FDBC) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

FIDELITY D & D BANCORP INC is the larger business by last-quarter revenue ($24.4M vs $21.8M, roughly 1.1× NEKTAR THERAPEUTICS). FIDELITY D & D BANCORP INC runs the higher net margin — 32.5% vs -165.4%, a 198.0% gap on every dollar of revenue. On growth, FIDELITY D & D BANCORP INC posted the faster year-over-year revenue change (15.0% vs -25.3%). FIDELITY D & D BANCORP INC produced more free cash flow last quarter ($24.8M vs $-65.0M). Over the past eight quarters, FIDELITY D & D BANCORP INC's revenue compounded faster (11.8% CAGR vs 0.4%).

Fidelity D & D Bancorp Inc is a US-based regional bank holding company primarily operating in northeastern Pennsylvania. It offers a full range of retail and commercial banking services including deposit accounts, consumer and business loans, mortgage lending, and wealth management solutions, catering to individual consumers, small businesses and local community clients.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

FDBC vs NKTR — Head-to-Head

Bigger by revenue
FDBC
FDBC
1.1× larger
FDBC
$24.4M
$21.8M
NKTR
Growing faster (revenue YoY)
FDBC
FDBC
+40.2% gap
FDBC
15.0%
-25.3%
NKTR
Higher net margin
FDBC
FDBC
198.0% more per $
FDBC
32.5%
-165.4%
NKTR
More free cash flow
FDBC
FDBC
$89.8M more FCF
FDBC
$24.8M
$-65.0M
NKTR
Faster 2-yr revenue CAGR
FDBC
FDBC
Annualised
FDBC
11.8%
0.4%
NKTR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FDBC
FDBC
NKTR
NKTR
Revenue
$24.4M
$21.8M
Net Profit
$7.9M
$-36.1M
Gross Margin
Operating Margin
37.7%
-126.9%
Net Margin
32.5%
-165.4%
Revenue YoY
15.0%
-25.3%
Net Profit YoY
36.1%
-596.9%
EPS (diluted)
$1.29
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FDBC
FDBC
NKTR
NKTR
Q4 25
$24.4M
$21.8M
Q3 25
$23.5M
$11.8M
Q2 25
$23.3M
$11.2M
Q1 25
$22.0M
$10.5M
Q4 24
$21.2M
$29.2M
Q3 24
$20.4M
$24.1M
Q2 24
$19.7M
$23.5M
Q1 24
$19.5M
$21.6M
Net Profit
FDBC
FDBC
NKTR
NKTR
Q4 25
$7.9M
$-36.1M
Q3 25
$7.3M
$-35.5M
Q2 25
$6.9M
$-41.6M
Q1 25
$6.0M
$-50.9M
Q4 24
$5.8M
$7.3M
Q3 24
$5.0M
$-37.1M
Q2 24
$4.9M
$-52.4M
Q1 24
$5.1M
$-36.8M
Gross Margin
FDBC
FDBC
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
72.7%
Q3 24
81.6%
Q2 24
58.5%
Q1 24
60.6%
Operating Margin
FDBC
FDBC
NKTR
NKTR
Q4 25
37.7%
-126.9%
Q3 25
36.5%
-268.6%
Q2 25
35.5%
-324.2%
Q1 25
32.2%
-425.8%
Q4 24
31.4%
49.2%
Q3 24
28.2%
-142.4%
Q2 24
28.9%
-211.9%
Q1 24
29.5%
-163.7%
Net Margin
FDBC
FDBC
NKTR
NKTR
Q4 25
32.5%
-165.4%
Q3 25
31.2%
-301.3%
Q2 25
29.7%
-372.2%
Q1 25
27.2%
-486.4%
Q4 24
27.5%
24.9%
Q3 24
24.3%
-153.6%
Q2 24
25.0%
-222.9%
Q1 24
25.9%
-170.1%
EPS (diluted)
FDBC
FDBC
NKTR
NKTR
Q4 25
$1.29
$-4.67
Q3 25
$1.27
$-1.87
Q2 25
$1.27
$-2.95
Q1 25
$1.03
$-0.24
Q4 24
$1.00
$-2.07
Q3 24
$0.86
$-2.66
Q2 24
$0.86
$-3.76
Q1 24
$0.88
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FDBC
FDBC
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$148.1M
$15.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$238.9M
$89.8M
Total Assets
$2.7B
$280.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FDBC
FDBC
NKTR
NKTR
Q4 25
$148.1M
$15.1M
Q3 25
$142.2M
$41.0M
Q2 25
$165.5M
$43.0M
Q1 25
$211.2M
$38.9M
Q4 24
$83.4M
$44.3M
Q3 24
$120.2M
$30.1M
Q2 24
$78.1M
$27.9M
Q1 24
$72.7M
$48.6M
Stockholders' Equity
FDBC
FDBC
NKTR
NKTR
Q4 25
$238.9M
$89.8M
Q3 25
$229.2M
$85.1M
Q2 25
$217.9M
$-24.2M
Q1 25
$211.7M
$13.7M
Q4 24
$204.0M
$60.7M
Q3 24
$207.3M
$48.9M
Q2 24
$195.7M
$79.7M
Q1 24
$191.6M
$126.7M
Total Assets
FDBC
FDBC
NKTR
NKTR
Q4 25
$2.7B
$280.4M
Q3 25
$2.7B
$301.3M
Q2 25
$2.7B
$207.5M
Q1 25
$2.7B
$256.2M
Q4 24
$2.6B
$303.9M
Q3 24
$2.6B
$308.0M
Q2 24
$2.5B
$343.3M
Q1 24
$2.5B
$396.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FDBC
FDBC
NKTR
NKTR
Operating Cash FlowLast quarter
$42.4M
$-65.0M
Free Cash FlowOCF − Capex
$24.8M
$-65.0M
FCF MarginFCF / Revenue
101.7%
-298.0%
Capex IntensityCapex / Revenue
71.9%
0.1%
Cash ConversionOCF / Net Profit
5.34×
TTM Free Cash FlowTrailing 4 quarters
$45.4M
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FDBC
FDBC
NKTR
NKTR
Q4 25
$42.4M
$-65.0M
Q3 25
$8.4M
$-48.8M
Q2 25
$12.6M
$-45.7M
Q1 25
$11.7M
$-49.1M
Q4 24
$29.6M
$-46.2M
Q3 24
$9.1M
$-43.9M
Q2 24
$8.7M
$-37.7M
Q1 24
$5.3M
$-47.9M
Free Cash Flow
FDBC
FDBC
NKTR
NKTR
Q4 25
$24.8M
$-65.0M
Q3 25
$2.2M
$-48.9M
Q2 25
$6.9M
$-45.8M
Q1 25
$11.5M
$-49.1M
Q4 24
$24.9M
$-46.6M
Q3 24
$7.8M
$-44.6M
Q2 24
$7.2M
$-37.9M
Q1 24
$4.0M
$-48.0M
FCF Margin
FDBC
FDBC
NKTR
NKTR
Q4 25
101.7%
-298.0%
Q3 25
9.3%
-414.5%
Q2 25
29.6%
-409.6%
Q1 25
52.3%
-469.0%
Q4 24
117.3%
-159.9%
Q3 24
38.1%
-184.9%
Q2 24
36.6%
-161.3%
Q1 24
20.7%
-222.0%
Capex Intensity
FDBC
FDBC
NKTR
NKTR
Q4 25
71.9%
0.1%
Q3 25
26.5%
1.0%
Q2 25
24.4%
0.3%
Q1 25
0.8%
0.0%
Q4 24
22.0%
1.6%
Q3 24
6.3%
2.8%
Q2 24
7.5%
0.8%
Q1 24
6.7%
0.7%
Cash Conversion
FDBC
FDBC
NKTR
NKTR
Q4 25
5.34×
Q3 25
1.15×
Q2 25
1.82×
Q1 25
1.95×
Q4 24
5.07×
-6.36×
Q3 24
1.83×
Q2 24
1.76×
Q1 24
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons